Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 12.38
+0.22 (1.81%)
At close: Jan 20, 2026
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 1.7 billion as of January 21, 2026. Its market cap has decreased by -4.81% in one year.
Market Cap
1.70B
Enterprise Value
1.43B
Revenue
130.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.38
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 1.70B, an increase of 1,184.57%. That is a compound annual growth rate of 22.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 1.67B | 7.99% |
| Dec 30, 2025 | 1.55B | -9.52% |
| Dec 30, 2024 | 1.71B | 182.47% |
| Dec 29, 2023 | 605.80M | -41.10% |
| Dec 30, 2022 | 1.03B | -9.66% |
| Dec 30, 2021 | 1.14B | -46.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 113.19B |
| Getinge AB | 57.85B |
| BioArctic AB | 46.50B |
| Sectra AB | 43.27B |
| Camurus AB | 39.51B |
| Medicover AB | 30.95B |
| Asker Healthcare Group AB | 29.69B |
| Elekta AB | 23.31B |